Innovating drug discovery and disease modeling using AI-powered novel screening pipelines with reliable predictive cell insights
Our technology is paving the way for pharmaceutical and biotechnology companies to reliably manufacture novel multifuctional therapeutics in less time and at lower cost
An AI-approach to screening and monitoring cell response with multiple applications in cancer research, tumor studies, tissue engineering and regenerative medicine
We leverage artificial intelligence to develop live-cell monitoring systems that enables drug response prediction with high sensitivity and specificity.